Amylyx Pharmaceuticals Enters Underwriting Agreement for Public Offering
On January 10, 2025, Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) announced its entry into an underwriting agreement with Leerink Partners LLC for the issuance and sale of 17,142,857 shares of its common stock at a price of $3.50 per share. The firm shares are part of the offering, with the possibility of an additional 2,571,428 shares […]
More Stories
Hawaii’s Big Island Prepares as Lala Strengthens to Hurricane Ahead of Possible Landfall
By Jeremy Lott Tropical Storm Lala has strengthened to a hurricane and could be the first to make landfall over...
US Tells EU ‘Now It’s Time to Deliver’ on Trade Commitments
By Bill Pan The United States is urging the European Union to further ease its corporate environmental rules, citing commitments...
Iran Accuses Qatar of Holding 3 of Its Military Pilots Captive
By Ryan Morgan The Iranian military, on Aug. 15, claimed three of its pilots are currently being held by Qatar,...
US Mortgage Rates Fall for First Time in 6 Weeks
By Naveen Athrappully The weekly average rate on a 30-year fixed-rate mortgage declined for the most recent week, breaking a...
What Battleground Voters Are Saying About Healthcare Affordability
By Lawrence Wilson “Yes, I do have opinions about this,” said Milwaukee resident Addaru Valentine just after voting in Wisconsin’s...
UAE Accuses Iran of Attacking Abu Dhabi National Oil Company Vessel in Strait of Hormuz
By Jacki Thrapp The United Arab Emirates (UAE) accused the Iranian regime of attacking an Abu Dhabi National Oil Company...